1. Home
  2. NTST vs MLTX Comparison

NTST vs MLTX Comparison

Compare NTST & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

N/A

Current Price

$17.39

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$11.47

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTST
MLTX
Founded
2019
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NTST
MLTX
Price
$17.39
$11.47
Analyst Decision
Buy
Buy
Analyst Count
20
15
Target Price
$22.92
★ $28.54
AVG Volume (30 Days)
1.1M
★ 1.6M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 5.09%
N/A
EPS Growth
★ 150.00
N/A
EPS
★ 0.12
N/A
Revenue
★ $195,006,000.00
N/A
Revenue This Year
$29.01
N/A
Revenue Next Year
$18.49
N/A
P/E Ratio
$149.63
★ N/A
Revenue Growth
★ 19.79
N/A
52 Week Low
$17.02
$7.50
52 Week High
$22.47
$23.29

Technical Indicators

Market Signals
Indicator
NTST
MLTX
Relative Strength Index (RSI) 18.87 31.71
Support Level $17.10 $11.06
Resistance Level $17.88 $19.24
Average True Range (ATR) 0.43 0.61
MACD -0.07 0.04
Stochastic Oscillator 0.80 14.63

Price Performance

Historical Comparison
NTST
MLTX

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: